Filing Details
- Accession Number:
- 0001567619-22-014301
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-21 16:11:42
- Reporting Period:
- 2022-07-19
- Accepted Time:
- 2022-07-21 16:11:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501989 | Cytomx Therapeutics Inc. | CTMX | Pharmaceutical Preparations (2834) | 273521219 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1682735 | C. Amy Peterson | C/O Cytomx Therapeutics, Inc. 151 Oyster Point Blvd., Ste. 400 South San Francisco CA 94080 | Evp, Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-07-19 | 20,000 | $0.00 | 70,153 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2022-07-20 | 7,463 | $1.42 | 62,690 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents Performance Stock Units ("PSUs") initially granted on October 24, 2021 that were subject to a performance-based vesting condition. The first milestone vesting condition was determined to be satisfied upon which 50% of the PSUs vested.
- Includes 40,000 restricted stock units.
- Reflects the adjusted total which includes the purchase of 3,732 shares under the Cytomx Therapeutics Employee Stock Purchase Plan on May 31, 2022.
- The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a PSU of the Issuer.
Billionaire Hedge Funds
